Midostaurin (Rydapt ®)

Midostaurin (Rydapt ®)
Product Description

Indication: Acute myeloid leukemia. Aggressive systemic mastocytosis - Under Development

Cyndea Pharma S.L

  • Country/Region:
    Spain
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    500 - 999
Company types
Manufacturer/Innovator

Cyndea Pharma S.L

  • Country/Region:
    Spain
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    500 - 999
Company types
Manufacturer/Innovator

More Products from Cyndea Pharma S.L (16)